Literature DB >> 16908217

Cardiovascular risk estimation by professionally active cardiovascular nurses: results from the Basel 2005 Nurses Cohort.

Wilma J M Scholte op Reimer1, Philip Moons, Sabina De Geest, Bengt Fridlund, Johanna Heikkilä, Tiny Jaarsma, Mattie Lenzen, Jan Martensson, Tone M Norekvål, Karen Smith, Simon Stewart, Anna Strömberg, David R Thompson.   

Abstract

BACKGROUND: Nurses play a key role in the prevention of cardiovascular disease (CVD) and one would, therefore, expect them to have a heightened awareness of the need for systematic screening and their own CVD risk profile. The aim of this study was to examine personal awareness of CVD risk among a cohort of cardiovascular nurses attending a European conference.
METHODS: Of the 340 delegates attending the 5th annual Spring Meeting on Cardiovascular Nursing (Basel, Switzerland, 2005), 287 (83%) completed a self-report questionnaire to assess their own risk factors for CVD. Delegates were also asked to give an estimation of their absolute total risk of experiencing a fatal CVD event in the next 10 years. Level of agreement between self-reported CVD risk estimation and their actual risk according to the SCORE risk assessment system was compared by calculating weighted Kappa (kappa(w)).
RESULTS: Overall, 109 responders (38%) self-reported having either pre-existing CVD (only 2%), one or more markedly raised CVD risk factors, a high total risk of fatal CVD (> or =5% in 10 years) or a strong family history of CVD. About half of this cohort (53%) did not know their own total cholesterol level. Less than half (45%) reported having a 10-year risk of fatal CVD of <1%, while 13% reported having a risk > or =5%. Based on the SCORE risk function, the estimated 10-year risk of a fatal CVD event was <1% for 96% of responders: only 2% had a > or =5% risk of such an event. Overall, less than half (46%) of this cohort's self-reported CVD risk corresponded with that calculated using the SCORE risk function (kappa(w)=0.27).
CONCLUSION: Most cardiovascular nurses attending a European conference in 2005 poorly understood their own CVD risk profile, and the agreement between their self-reported 10-year risk of a fatal CVD and their CVD risk using SCORE was only fair. Given the specialist nature of this conference, our findings clearly demonstrate a need to improve overall nursing awareness of the role and importance of systematic CVD risk assessment.

Entities:  

Mesh:

Year:  2006        PMID: 16908217     DOI: 10.1016/j.ejcnurse.2006.06.007

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  5 in total

1.  Views of general practice staff about the use of a patient-oriented treatment decision aid in shared decision making for patients with type 2 diabetes: A mixed-methods study.

Authors:  Anita Wildeboer; Esther du Pon; Jan Schuling; Flora M Haaijer-Ruskamp; Petra Denig
Journal:  Health Expect       Date:  2017-06-21       Impact factor: 3.377

2.  Informed shared decision-making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial.

Authors:  Susanne Buhse; Nadine Kuniss; Kathrin Liethmann; Ulrich Alfons Müller; Thomas Lehmann; Ingrid Mühlhauser
Journal:  BMJ Open       Date:  2018-12-14       Impact factor: 2.692

3.  A survey on critical health competences among diabetes educators using the Critical Health Competence Test (CHC Test).

Authors:  Lars Hecht; Gabriele Meyer; Anke Steckelberg
Journal:  BMC Med Educ       Date:  2021-02-09       Impact factor: 2.463

Review 4.  Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.

Authors:  Stacey L Sheridan; Eric Crespo
Journal:  BMC Health Serv Res       Date:  2008-03-20       Impact factor: 2.655

5.  Perceived Preparedness of Health Care Students for Providing Cardiovascular Disease Risk Assessment and Management.

Authors:  Monica Zolezzi; Oraib Abdallah; Suad Aden; Stella Major; Diana White; Alla El-Awaisi
Journal:  Pharmacy (Basel)       Date:  2017-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.